Generalizing Clinical Trial Results to a Target Population

References

• Barnard, J., Frangakis, C. E., Hill, J. L., and Rubin, D. B. (2003), “Principal Stratification Approach to Broken Randomized Experiments: A Case Study of School Choice Vouchers in New York City,” Journal of the American Statistical Association, 98, 299–323. DOI: 10.1198/016214503000071.
   Web of Science ®Google Scholar
• Campbell, D. T. (1957), “Factors Relevant to the Validity of Experiments in Social Settings,” Psychological Bulletin, 54, 297–312. DOI: 10.1037/h0040950.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control & Prevention. National Health & Nutrition Examination Survey. Available at https://wwwn.cdc.gov/nchs/nhanes/Default.aspx.
   Google Scholar
• Cole, S. R., and Stuart, E. A. (2010), “Generalizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 Trial,” American Journal of Epidemiology, 172, 107–115. DOI: 10.1093/aje/kwq084.
   PubMed Web of Science ®Google Scholar
• Dahabreh, I. J., Robertson, S. E., and Hernán, M. A. (2019), “On the Relation Between g-Formula and Inverse Probability Weighting Estimators for Generalizing trial Results,” Epidemiology, 30, 807–812. DOI: 10.1097/EDE.0000000000001097.
   PubMed Web of Science ®Google Scholar
• Data Access and Dissemination Systems. (2000), American factfinder.
   Google Scholar
• Efron, B., and Feldman, D. (1991), “Compliance as an Explanatory Variable in Clinical Trials,” Journal of the American Statistical Association, 86, 9–17.
   Web of Science ®Google Scholar
• Hill, J., Rubin, D. B., and Thomas, N. (2000), “The Design of the New York School Choice Scholarship Program Evaluation,” Validity and Social Experimentation: Donald Campbell’s Legacy, 1, 155–180.
   Google Scholar
• Imbens, G. W., and Rubin, D. B. (2015), Causal Inference in Statistics, Social, & Biomedical Sciences, Cambridge: Cambridge University Press.
   Google Scholar
• Julian, D. G., Jackson, F. S., Prescott, R. J., and Szekely, P. (1982), “Controlled Trial of Sotalol for One Year After Myocardial Infarction,” The Lancet, 319, 1142–1147. DOI: 10.1016/S0140-6736(82)92225-5.
   Google Scholar
• Lane, P. W., and Nelder, J. A. (1982), “Analysis of Covariance and Standardization as Instances of Prediction,” Biometrics, 38, 613–621. DOI: 10.2307/2530043.
   PubMed Web of Science ®Google Scholar
• Lesko, C. R., Buchanan, A. L., Westreich, D., Edwards, J. K., Hudgens, M. G., and Cole, S. R. (2017), “Generalizing Study Results: A Potential Outcomes Perspective,” Epidemiology, 28, 553–561. DOI: 10.1097/EDE.0000000000000664.
   PubMed Web of Science ®Google Scholar
• Lipid Research Clinic Program. (1984), “The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in Incidence of Coronary Heart Disease,” JAMA, 251, 351–364.
   PubMed Web of Science ®Google Scholar
• Murthy, V. H., Krumholz, H. M., and Gross, C. P. (2004), “Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities,” JAMA, 291, 2720–2726. DOI: 10.1001/jama.291.22.2720.
   PubMed Web of Science ®Google Scholar
• Nguyen, T. Q., Ebnesajjad, C., Cole, S. R., and Stuart, E. A. (2017), “Sensitivity Analysis for an Unobserved Moderator in RCT-to-Target-Population Generalization of Treatment Effects,” The Annals of Applied Statistics, 11, 225–247. DOI: 10.1214/16-AOAS1001.
   Web of Science ®Google Scholar
• NYC Department of City Planning (2000), Decennial Census.
   Google Scholar
• O’Muircheartaigh, C., and Hedges, L. V. (2014), “Generalizing From Unrepresentative Experiments: A Stratified Propensity Score Approach,” Journal of the Royal Statistical Society, Series C, 63, 195–210.
   Web of Science ®Google Scholar
• Post, P. N., de Beer, H., and Guyatt, G. H. (2013), “How to Generalize Efficacy Results of Randomized Trials: Recommendations Based on a Systematic Review of Possible Approaches,” Journal of Evaluation in Clinical Practice, 19, 638–643. DOI: 10.1111/j.1365-2753.2012.01888.x.
   PubMed Web of Science ®Google Scholar
• Rosenbaum, P. R., and Rubin, D. B. (1984), “Reducing Bias in Observational Studies Using Subclassification on the Propensity Score,” Journal of the American Statistical Association, 79, 516–524.
   Web of Science ®Google Scholar
• Stuart, E. A., Bradshaw, C. P., and Leaf, P. J. (2015), “Assessing the Generalizability of Randomized Trial Results to Target Populations,” Prevention Science, 16, 475–485. DOI: 10.1007/s11121-014-0513-z.
   PubMed Web of Science ®Google Scholar
• Stuart, E. A., Cole, S. R., Bradshaw, C. P., and Leaf, P. J. (2011), “The Use of Propensity Scores to Assess the Generalizability of Results From Randomized Trials,” Journal of the Royal Statistical Society, Series A, 174, 369–386. DOI: 10.1111/j.1467-985X.2010.00673.x.
   Web of Science ®Google Scholar
• Stuart, E. A., and Green, K. M. (2008), “Using Full Matching to Estimate Causal Effects in Nonexperimental Studies: Examining the Relationship Between Adolescent Marijuana Use and Adult Outcomes,” Developmental Psychology, 44, 395–406. DOI: 10.1037/0012-1649.44.2.395.
   PubMed Web of Science ®Google Scholar
• Unger, J. M., Cook, E., Tai, E., and Bleyer, A. (2016), “The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies,” American Society of Clinical Oncology Educational Book, 36, 185–198. DOI: 10.1200/EDBK_156686.
   Google Scholar
• Weiss, N. S. (2007), “Generalizability of Cancer Clinical Trial Results,” Cancer, 109, 341. DOI: 10.1002/cncr.22390.
   PubMed Web of Science ®Google Scholar
• Westreich, D., Edwards, J. K., Lesko, C. R., Stuart, E., and Cole, S. R. (2017), “Transportability of Trial Results Using Inverse Odds of Sampling Weights,” American Journal of Epidemiology, 186, 1010–1014. DOI: 10.1093/aje/kwx164.
   PubMed Web of Science ®Google Scholar